ESC Premium Access

COVID-19 and percutaneous intervention

Event: ESC Congress 2021 - The Digital Experience
Topic: Diseases of the Aorta
Session type: Abstract Sessions
Date: 29 August 2021
Time: 20:15 - 21:00

Congress Session

4 presentations in this session

Assessment of vascular endothelial function in COVID-19 patients

Speaker: Doctor H. Mejia Renteria (Madrid, ES)

Soluble urokinase-type plasminogen activator receptor (suPAR) is associated with risk for thromboembolic complications and mortality in patients with COVID-19

Speaker: Doctor S. Luo (Chicago, US)

Impact of COVID-19 lockdowns on STEMI percutaneous interventions

Speaker: Doctor V. Zlochiver (Milwaukee, US)

Stroke mechanisms associated with coronavirus disease (COVID-19)

Speaker: Professor M. Kruchinina (Novosibirsk, RU)

4 speakers from this session

Doctor Hernan Mejia Renteria

San Carlos Clinical University Hospital, Madrid (Spain)
0 follower

Doctor Shengyuan Luo

Rush University Medical Center, Chicago (United States of America)
0 follower

Doctor Viviana Zlochiver

Advocate Aurora Health, Milwaukee (United States of America)
0 follower

Professor Margarita Kruchinina

Research institute of internal and preventive medicine branch of Institute of Cytology and Genetics , Novosibirsk (Russian Federation)
0 follower

This platform is supported by

logo Novo Nordisk